ClinicalTrials.gg
CompletedNCT05473065Updated Sep 9, 2026

A Prosthetic Foot Test-Drive Strategy for Improving Stability in Veterans With Leg Amputations

An interventional study of Multiaxial Prosthetic Foot Emulator and Commercially available prosthetic feet in Amputation, sponsored by Seattle Institute for Biomedical and Clinical Research. Completed at 2 sites in United States. Open to participants aged 18 Years to 89 Years. Per ClinicalTrials.gov, last updated 2026-09-09.

Sponsored by Seattle Institute for Biomedical and Clinical Research · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
46
Allocation
Randomized
Ages
18 Years to 89 Years
Sex
All
01

Study summary

Objective/Hypotheses and Specific Aims: The first aim of this proposal is to determine the effects of commercial prosthetic feet of varying stiffness on stability and falls-related outcomes in Veterans with TTA. The second aim is to determine whether a PFE can be used to predict stability and balance-confidence outcomes with corresponding commercial prosthetic feet. The third and final aim is to determine whether a brief trial of commercial prosthetic feet can predict longer-term stability and balance-confidence outcomes in Veterans with TTA.

Study Design: The investigators will use a participant blinded cross-over study with repeated measurements in Veterans and Service members with TTA. Up to 50 participants will be enrolled at each of the two study sites VA Puget Sound and VA Minneapolis. Participants will complete up to 6 visits. After an initial assessment visit, participants will be assigned to the 'high' or 'low' mobility group, and then during visit 2 they will be randomized to use the PFE in three foot modes or the three corresponding actual (commercially available) feet during walking tests on difference surfaces in the laboratory (cross-slopes, inclines, even, and uneven ground). During visit 3 participants will repeat the procedures in the other condition (e.g., PFE if visit 2 included actual feet testing). At the end of visit 3 participants will be fit with one of the actual feet and wear it at home and in the community for approximately one week. At visit 4 participants will be fit with the next actual foot and repeat the 1 week use window. The same process will be followed for the final foot at visit 5, and the study foot will be returned at visit 6.

Read the detailed description

Using a prosthesis allows many who experience lower leg amputation to regain functional abilities, but walking may be more difficult, and people with limb loss suffer from a wide range of mobility limitations including balance and stability impairments. Selecting an optimal prosthetic foot is an important aspect of maximizing mobility, limiting falls, and the achievement of functional goals for people with lower leg amputation (LLA), however there is limited evidence to guide this process. The current prosthetic prescription process relies on clinician experience and typically does not allow people with a leg amputation to easily try out different prosthetic feet. The investigators have developed a customizable robotic prosthetic foot that can mimic the mechanical properties of commercially available prosthetic feet in the coronal and sagittal planes without physically changing feet. This multiaxial 'prosthetic foot emulator' (PFE) can be attached to the prescribed prosthetic socket and worn like a regular prosthetic foot within the laboratory or clinic, providing people with LLA the opportunity to quickly 'test-drive' many prosthetic foot designs within a single test session. Trial and error with actual commercial prosthetic feet can be inefficient given the time and expense required for the purchasing and fitting of prosthetic feet. The PFE could provide a means to explore a range of feet over uneven, incline, and cross sloped surfaces in a very short period of time. This study aims to optimize stability and balance-related outcomes, to minimize falls, and to optimize vocational and avocational participation and functional quality for life for Veterans with LLA. This study will determine the effects of coronal and sagittal plane commercially-available prosthetic foot stiffness on stability and falls related outcomes and will evaluate the use of a test-drive strategy using a PFE to predict stability and balance-confidence outcomes with corresponding commercial prosthetic feet. Results from this study may contribute to increased understanding of how a patient-centered strategy for optimizing prosthetic prescription can improve patient satisfaction, functional outcomes, and balance confidence for Veterans and others with LLA.

02

Conditions studied

  • Amputation

Keywords

  • amputation
  • rehabilitation
  • balance
  • stability
  • falls
  • emulator
  • prosthetics
03

In context

Lead sponsor

Seattle Institute for Biomedical and Clinical Research is the lead sponsor of 49 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 89 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • has a unilateral (one leg) transtibial (below-knee) amputation
  • has used a prosthetic limb for walking for at least six months
  • has a comfortably fitting prosthetic socket
  • has a removable prosthetic foot attachment (i.e., is not rigidly attached to the back of the socket) so it can be used with study prosthetic feet
  • be able to walk with a prosthetic limb sufficiently to participate in the experiment walking trials

Exclusion criteria

Exclusion Criteria:

  • contralateral limb or upper limb amputation that would interfere with completion of study activities
  • are unable to use more than one of the test feet for any reason (e.g., excessively long residual limb that is not compatible with wearing study prosthetic feet)
  • unable to walk under the minimal necessary study walking conditions in order to complete the study procedures without undo stress
  • current surgical, neurological, rheumatologic, or lower limb musculoskeletal problem that significantly impairs ambulation (e.g., current ulcer, terminal illness)
  • weight greater than 263lbs.
  • inadequate cognitive or language function to consent to participate
  • currently incarcerated
  • impaired decision-making ability or the use of a legally authorized representative
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Participant)
Enrollment
46 participants (actual)

Study arms

  • Experimental
    Multiaxial Prosthetic Foot Emulator (PFE)

    The multiaxial Prosthetic Foot Emulator (PFE) is a customizable robotic prosthetic foot that can mimic commercial feet to predict how prosthesis users will respond to candidate feet. Participants will walk with the PFE using three different modes (emulating three commercial feet) under different walking conditions.

    Device: Multiaxial Prosthetic Foot Emulator

  • Active comparator
    Commercially available prosthetic feet

    Participants will walk under different walking conditions using three different commercial prosthetic feet.

    Device: Commercially available prosthetic feet

Interventions

  • DeviceMultiaxial Prosthetic Foot Emulator

    Participants will walk in the laboratory with the multiaxial Prosthetic Foot Emulator (PFE) in three foot modes corresponding to commercial prosthetic study feet. Walking conditions will include self-selected comfortable, slow, and fast speeds, inclines, cross slopes, and uneven terrain.

  • DeviceCommercially available prosthetic feet

    Participants will walk in the laboratory with the commercial prosthetic study feet in three foot modes corresponding to commercial prosthetic study feet. Walking conditions will include self-selected comfortable, slow, and fast speeds, inclines, cross slopes, and uneven terrain. Additionally, participants will be fit with one of the commercial prosthetic study feet and wear it at home and in the community for approximately one week. Participants will return to the laboratory to follow-up testing, and will complete the community trial with each of the three commercial prosthetic study feet.

06

What researchers measure

Primary outcomes

  1. Self-report: perceived stability

    Correlation between prosthetic foot sagittal and coronal plane stiffness properties and perceived stability during walking on uneven ground and cross-slopes

    Time frame: Administered at baseline and during follow up testing with the commercial feet (approximately 2 hours)

  2. Biomechanical measures: Medial/Lateral Margin of Stability (MOS)

    Correlation between prosthetic foot sagittal and coronal plane stiffness properties and Medial/Lateral Margin of Stability (MOS) during walking on uneven ground and cross-slopes

    Time frame: Administered during follow up testing with the commercial feet (approximately 2 hours)

  3. Performance-based outcomes: Narrowing Beam Walking Test

    Correlation between prosthetic foot sagittal and coronal plane stiffness properties and Narrowing Beam Walking Test score.

    Time frame: Administered at baseline with the commercial feet (approximately 2 hours)

  4. Performance-based outcomes: Narrowing Beam Walking Test

    Correlation between prosthetic foot sagittal and coronal plane stiffness properties and Narrowing Beam Walking Test score.

    Time frame: Administered during follow up testing with the commercial feet (approximately 2 hours)

  5. Performance-based outcomes: Four Square Step Test

    Correlation between prosthetic foot sagittal and coronal plane stiffness properties and Four Square Step Test score.

    Time frame: Administered at baseline with the commercial feet (approximately 2 hours)

  6. Performance-based outcomes: Four Square Step Test

    Correlation between prosthetic foot sagittal and coronal plane stiffness properties and Four Square Step Test score.

    Time frame: Administered during follow up testing with the commercial feet (approximately 2 hours)

  7. Self-report: balance confidence Activities-specific Balance Confidence

    Correlation between prosthetic foot sagittal and coronal plane stiffness properties and Activities-specific Balance Confidence (ABC) score

    Time frame: Administered at baseline with the commercial feet (approximately 2 hours)

  8. Self-report: Activity Restriction PROMIS Ability to Participate in Social Roles and Activities (APSRA)

    Correlation between prosthetic foot sagittal and coronal plane stiffness properties and PROMIS Ability to Participate in Social Roles and Activities (APSRA)

    Time frame: Administered at baseline with the commercial feet (approximately 2 hours)

  9. Self-report: Activity Restriction PROMIS Ability to Participate in Social Roles and Activities (APSRA)

    Correlation between prosthetic foot sagittal and coronal plane stiffness properties and PROMIS Ability to Participate in Social Roles and Activities (APSRA)

    Time frame: Administered during follow up testing with the commercial feet (approximately 2 hours)

  10. Self-report: perceived stability with emulated feet and commercial feet

    Correlation between participants self-report perceived stability using the multiaxial prosthetic foot emulator and the commercial prosthetic study feet

    Time frame: Administered during initial testing with emulated and actual prosthetic feet (approximately two hours)

  11. Self-report: perceived stability with emulated feet and balance confidence using corresponding commercial feet

    Correlation between participants self-report perceived stability using the multiaxial prosthetic foot emulator during initial testing and their balance confidence using the Activities-specific Balance Confidence during follow up with the corresponding commercial prosthetic foot

    Time frame: Administered during initial testing with emulated feet (approximately two hours)

  12. Self-report: perceived stability with emulated feet and balance confidence using corresponding commercial feet

    Correlation between participants self-report perceived stability using the multiaxial prosthetic foot emulator during initial testing and their balance confidence using the Activities-specific Balance Confidence during follow up with the corresponding commercial prosthetic foot

    Time frame: Administered at follow up using the actual prosthetic feet (approximately two hours)

  13. Self-report: perceived stability with emulated feet and performance-based measures of stability (NBWT and FSST) using corresponding commercial feet

    Correlation between participants self-report perceived stability using the multiaxial prosthetic foot emulator during initial testing and their performance-based stability using the Narrowing Beam Walking Test (NBWT) and Four Square Step Test (FSST) during follow up with the corresponding commercial prosthetic foot

    Time frame: Administered during initial testing with emulated feet (approximately two hours)

  14. Self-report: perceived stability with emulated feet and performance-based measures of stability (NBWT and FSST) using corresponding commercial feet

    Correlation between participants self-report perceived stability using the multiaxial prosthetic foot emulator during initial testing and their performance-based stability using the Narrowing Beam Walking Test (NBWT) and Four Square Step Test (FSST) during follow up with the corresponding commercial prosthetic foot

    Time frame: Administered at follow up using the actual prosthetic feet (approximately two hours)

  15. Self-report: initial perceived stability and follow-up perceived stability

    Correlation between initial perceived stability with each actual foot (relative to other feet) and perceived stability with the corresponding foot at follow-up

    Time frame: Administered during initial testing with the actual feet (approximately two hours)

  16. Self-report: initial perceived stability and follow-up perceived stability

    Correlation between initial perceived stability with each actual foot (relative to other feet) and perceived stability with the corresponding foot at follow-up

    Time frame: Administered at follow up using the actual prosthetic feet (approximately two hours)

  17. Self-report: initial perceived stability and follow-up performance-based based measures of stability

    Correlation between initial perceived stability with each actual foot (relative to other feet) and performance-based stability using the Narrowing Beam Walking Test (NBWT) and Four Square Step Test (FSST) during follow up with the corresponding commercial prosthetic foot

    Time frame: Administered during initial testing with actual feet (approximately two hours)

  18. Self-report: initial perceived stability and follow-up performance-based based measures of stability

    Correlation between initial perceived stability with each actual foot (relative to other feet) and performance-based stability using the Narrowing Beam Walking Test (NBWT) and Four Square Step Test (FSST) during follow up with the corresponding commercial prosthetic foot

    Time frame: Administered at follow up using the actual prosthetic feet (approximately two hours)

07

Study locations

2 sites
  • Minneapolis VA Medical Center
    Minneapolis, Minnesota 55417, United States
  • VA Puget Sound Health Care System
    Seattle, Washington 98108, United States
08

References and documents

Publications

  • Ho TK, Halsne EG, Koehler-McNicholas SR, Hansen AH, Sawers A, Caputo JM, Curran CS, Lloyd A, Cave J, Morgenroth DC. Assessing the effects of prosthetic foot stiffness and foot preference on stability, balance confidence, and satisfaction in transtibial prosthesis users: Protocol for a randomized, participant-masked crossover trial using a 'test-drive' strategy. PLoS One. 2025 Oct 22;20(10):e0334497. doi: 10.1371/journal.pone.0334497. eCollection 2025. PubMed 41124130 ↗

Individual participant data

Plan to share: Undecided

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Mar 2024 to primary completion in Jul 2026, 28 months.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 23, 2022
First posted
Jul 25, 2022
StartActual
Mar 1, 2024
Primary completionActual
Jul 31, 2026
CompletionActual
Jul 31, 2026
Last update
Sep 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 9, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05473065
Lead sponsor
Seattle Institute for Biomedical and Clinical Research
Collaborators
VA Puget Sound Health Care System, Minneapolis Veterans Affairs Medical Center, University of Chicago
Responsible party
Sponsor
First posted
Jul 25, 2022
Start date
Mar 1, 2024
Primary completion
Jul 31, 2026
Completion
Jul 31, 2026
Last update
Sep 9, 2026

Study contacts

David C Morgenroth, MD
principal investigator · VA Puget Sound Health Care System

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion